Výsledky vyhledávání - "Aaron W Scheffler"

Akademický článek

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy

Autor: Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Joanne Weidhaas, Mark Scholz, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Donatello Telesca

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)

Background There is great interest in finding ways to identify patients who will develop toxicity to cancer therapies. This has become especially pressing in the era of immune therapy, where toxicity can be long-lasting and life-altering, and primari

Externí odkaz: https://doaj.org/article/e2019815fc4c4bd1be2b11529a99a478

Zobrazit plný text záznamu

Akademický článek

Properties of beta oscillations in Dup15q syndrome

Autor: Vidya Saravanapandian, Joel Frohlich, Joerg F. Hipp, Carly Hyde, Aaron W. Scheffler, Peyman Golshani, Edwin H. Cook, Lawrence T. Reiter, Damla Senturk, Shafali S. Jeste

Publikováno v: Journal of Neurodevelopmental Disorders, Vol 12, Iss 1, Pp 1-15 (2020)

Abstract Background Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism, intellectual disability, hypotonia, and epilepsy. The 15q region harbors genes critical for brain development, particularly UBE3A and a cluster of ga

Externí odkaz: https://doaj.org/article/e15855b4fa354cdb8f21be5a7ddd9caf

Zobrazit plný text záznamu

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy

Autor: Joanne Weidhaas, Nicholas Marco, Aaron W Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P Raja, Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Mark Scholz, Donatello Telesca

Publikováno v: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Journal for immunotherapy of cancer, vol 10, iss 2

BackgroundThere is great interest in finding ways to identify patients who will develop toxicity to cancer therapies. This has become especially pressing in the era of immune therapy, where toxicity can be long-lasting and life-altering, and primaril

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057217867d2e1f09df31d2eaff05f0aa
https://doi.org/10.1136/jitc-2021-003625

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání